When a company is fairly certain of a profit margin that is substantial, it can assume responsibility for the clinical trials to develop a blockbuster drug.

We feel confident that there won't be an outbreak.

One of the by-products of being a perfectionist and constantly trying to improve myself are sobering feelings of low-grade anxiety and a nagging sense of inadequacy This anxiety keeps me humble.

Investigating rare diseases gives researchers more clues about how the healthy immune system functions.

The launch of phase 1 Ebola vaccine studies is a first step in developing a vaccine that could be licensed and used in the field to protect not only the front line health care workers but also those living in areas where Ebola virus exists.

I run a modest-sized laboratory thats looking specifically at what we call the pathogenic mechanisms of HIV disease, or AIDS.

What has happened over the years is that scientists have now developed AIDS therapeutic capabilities, as well as prevention, and we've linked prevention and treatment in a way that if you fast-forward 30 years form '88 to now, we can say without hyperbole that we have the tools, if implemented the way they could be implemented, to theoretically, essentially end the epidemic as we know it now.